Labcorp expands molecular bioanalytical laboratory in Greenfield

The expanded facility will increase Labcorp’s global molecular bioanalytical capacity.

Labcorp, a global leader of innovative and comprehensive laboratory services, announced the expansion of its molecular bioanalytical laboratory in Greenfield.

The expanded facility will increase Labcorp’s global molecular bioanalytical capacity, enabling the company to help biopharmaceutical customers bring life-saving advanced therapies to patients faster.

"For more than 20 years, Labcorp has been at the forefront of innovation in molecular bioanalysis, leveraging our extensive experience and industry-leading insights to help biopharmaceutical customers advance their most challenging drug development projects," said Megan Bailey, EVP and president, Central Laboratory Services and International for Labcorp. “This expansion underscores our broader strategy of investing in capabilities that reduce lead times for molecular bioanalysis and reinforces our commitment to accelerating the development of advanced therapies, including cell and gene therapies, for patient populations in critical need."

Today, Labcorp operates three global molecular bioanalytical facilities, including those in Greenfield, Indiana, Harrogate, U.K., and Shanghai, China. The expanded Greenfield facility is equipped to support the development and validation of preclinical and clinical molecular bioanalytical assays required for advanced therapies such as cell and gene therapies for oncology, rare disease and other therapeutic areas.

The Shelby County Post is a digital newspaper producing news, sports, obituaries and more without a pay wall or subscription needed.